会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • MORAXELLA POLYPEPTIDES AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
    • 莫拉赛尔多糖和相应的DNA片段及其用途
    • WO0218595A9
    • 2007-08-23
    • PCT/CA0101221
    • 2001-08-28
    • AVENTIS PASTEURLOOSMORE SHEENAWANG JOEBRADLEY BILLOCHS MARTINAYANG YAN-PING
    • LOOSMORE SHEENAWANG JOEBRADLEY BILLOCHS MARTINAYANG YAN-PING
    • A61K39/00C07K14/21C12N1/21C12N7/01C12N15/31
    • C07K14/212A61K39/00A61K2039/505A61K2039/53C07K2319/00C12N2799/023
    • The present invention provides nucleic acids, proteins and vectors for immunization of a host, including humans, against disease caused by infection by a strain of Moraxella, specifically M. catarrhalis. The invention includes DNA vaccination methods which employ a vector containing a nucleotide sequence encoding a protein of a strain of Moraxella, specifically M. catarrhalis, and a promoter to effect expression of the protein gene product in the host. The nucleotide sequences include those which encode: a major anaerobically induced OMP, rare lipoprotein A proteins, component proteins of the adhesin complex, a potential lipoprotein OMP, a putative oxidoreductase, OprM, collagenase, outer membrane phopholipase A, lipoproteins, OmpA, NADH:ubiquinone oxidoreductase subunit, pilQ fimbriae, invasin protein, a 36 kDa secreted protein, OMP, Outer membrane esterase, pyridine nucleotide transhydrogenase, HecB, a putative virulence factor, heme receptor, ompC, heme receptor, and porin.
    • 本发明提供用于免疫宿主(包括人)的核酸,蛋白质和载体,其针对由莫拉氏菌菌株,特别是卡他莫拉菌感染引起的疾病。 本发明包括DNA疫苗接种方法,其使用含有编码莫拉氏菌菌株,特别是卡他莫拉菌的蛋白质的核苷酸序列的载体,以及在宿主中影响蛋白质基因产物表达的启动子。 核苷酸序列包括编码:主要的厌氧诱导的OMP,罕见的脂蛋白A蛋白,粘附素复合物的组分蛋白,潜在的脂蛋白OMP,推定的氧化还原酶,OprM,胶原酶,外膜磷脂酶A,脂蛋白,OmpA,NADH: 泛醌氧化还原酶亚基,pilQ菌毛,invasin蛋白,36kDa分泌蛋白,OMP,外膜酯酶,吡啶核苷酸转氢酶,HecB,推定的毒力因子,血红素受体,ompC,血红素受体和孔蛋白。